
Oncolytic Virotherapy Summit
03-05 Décembre 2019, Boston, Massachusetts, États-Unis
Réf : 30424
Evènement :Oncolytic Virotherapy Summit
Dates :Mardi 03 Décembre 2019 - Jeudi 05 Décembre 2019
Lieu :The Westin Boston Waterfront
425 Summer Street
02210 Boston, Massachusetts, États-Unis
Type :Conférence & Séminaire - Audience Internationale
Accréditation :--
Informations
The Oncolytic Virotherapy Summit is back for its fifth year as the only conference to bring together industry leaders, clinicians and academic experts focused on finding an effective immuno-oncology.
Over 3 days packed with compelling case studies, diverse panels and varied networking opportunities, you'll glean insights from industry and academic leaders. The 2019 agenda will reflect the strides taken by the community over the past year as well as forming the future of oncolytic virus development.
URLs:
Time: 08:00 to 16:00
Prices:
Conference Only : USD 2399.0,
Conference + 1 Workshop: USD 2999.0,
Conference + 2 Workshops: USD 3399.0
Speakers: Lance Weed, Vice President Operations, uniQure, Anton Xavier, Founder, K9 Biotech, Michael Wood MBA, Founder and Chief Operating Officer, OncoMyx, Robert Coffin, CEO, Replimmune, Daniel Katzman, CEO, Unleash Immuno Oncolytics, Dr Erik Digman Wiklund, Chief Business Officer, Targovax ASA, Michael Moore, Vice President Investor Relations and Corporate Communications, Oncolytics Biotech, David Sherris, President and Chief Executive Officer, GenAdam Therapeutics Inc., Louis Cantolupo, Chief Operating Officer, Unleash Immuno Oncolytics, Christophe Quéva, Chief Scientific Officer, Oncorus, Sridhar Pennathur, Senior Director and Fellow Biopharmaceutical Development, AstraZeneca, Dr John Goldberg, Senior Vice President Clinical Development and Practicing Paediatric Oncologist, Oncorus, Brian Haines PhD, Senior Director Pharmacology and Toxicology, Oncorus, Lorena Lerner, Vice President Molecular Biology and Virology, Oncorus, Beatriz Mesa, Senior Director Oncolytic Virus Manufacturing, Sorrento Therapeutics, Steve Thorne, Chief Scientific Officer, Western Oncolytics, Shara Dellatore, Principal Scientist and Group Leader, Merck, Angelica Loskog, CEO, Lokon Pharma, Maritza McIntyre, Former Chief Gene Therapy Branch, FDA
Lieu
Adresse de la conférence :
The Westin Boston Waterfront
425 Summer Street
02210 Boston
Massachusetts, États-Unis
Plan et itinéraire
The Westin Boston Waterfront
425 Summer Street
02210 Boston
Massachusetts, États-Unis
Plan et itinéraire
Renseignements
Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!
Annonceur
Divers
Pour plus d'informations sur Oncolytic Virotherapy Summit, veuillez contacter Hanson Wade
Pour obtenir une lettre d'invitation, vous devez être connecté
Ajout à la sélection ...
Recommander cet évènement
Ajouter l'évènement à mon agenda personnel